Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041728 | SCV000065424 | pathogenic | Rare genetic deafness | 2011-11-30 | criteria provided, single submitter | clinical testing | The Tyr4238X variant in USH2A has not been reported in the literature nor previo usly identified by our laboratory. The Tyr4238X variant leads to a premature sto p codon at position 4238, which is predicted to lead to a truncated or absent pr otein. In summary, this variant meets our criteria to be classified as pathogeni c. |
Labcorp Genetics |
RCV001852858 | SCV002240279 | pathogenic | not provided | 2023-10-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr4238*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 23352160). ClinVar contains an entry for this variant (Variation ID: 48405). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003450767 | SCV004181953 | pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing |